Statistics

Total Visits

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study50

Select a period of time:

Number of views in the range

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study9

Views

Views
October 20251
November 20255
December 20250
January 20260
February 20260
March 20263
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom3
United States2
Brazil2
Finland1
Venezuela1
 

Top cities views

Views
Council Bluffs2
Helsinki1
São Paulo1
Vitória de Santo Antão1